home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

An Alternative to Viagra?

 
  January, 5 2001 3:30
your information resource in human molecular genetics
 
     
Viagra has become a best-selling drug because of its ability to combat impotence. It works by increasing the dilatory effects of nitric oxide on blood vessels in the penis. Now, scientists at the University of Michigan may have discovered a different pharmacological way of causing erection Nature Medicine (Vol. 7, Issue 1, 01 Jan 2001).

Based on the hypothesis that removing an over-riding constriction of blood vessels in the penis—rather than actively causing vasodilation as Viagra does—can result in erection, Kanchan Chitaley and colleagues tested the ability of a compound called Y-27632 to cause penile erection in an animal model.

Y-27632 works by blocking a molecule called rho kinase, which activates myosin light chain, the contractile machinery of muscle tissue. When injected into rats, Y-27632 increased pressure in the corpus cavernosum—the erectile tissue in the penis—and caused erection.

CONTACT:

Dr. Kanchan Chitaley
Department of Physiology
University of Michigan
Ann Arbor, Michigan 48109
USA
Tel: +1 706 721 2781
Fax: +1 706 721 7299
Email: kanchanc@umich.edu

(C) Nature Medicine press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.